Jordan Shin
Chief Tech/Sci/R&D Officer chez RENOVACOR, INC.
Profil
Jordan Shin is currently working as the SVP of Clinical Development & Translational Science at Renovacor, Inc. Prior to this, he completed his undergraduate degree from The University of Alabama School of Medicine.
Postes actifs de Jordan Shin
| Sociétés | Poste | Début |
|---|---|---|
| RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Jordan Shin
| The University of Alabama School of Medicine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
